A new large-scale study in cardiology and microbiome science has revealed a strong link between the composition of the gut microbiota and the clinical course of heart failure patients…
Translated from the Turkish original by DoktorClub. The Turkish version is the reference text; this English translation has not been separately reviewed by a physician. Read the Turkish original.
A new large-scale study in cardiology and microbiome science has revealed a strong link between the composition of the gut microbiota and the clinical course of heart failure patients. According to the published study, a high proportion of certain beneficial bacterial species in the gut flora reduces patients' risk of hospitalization and markedly increases overall survival rates.
In the study, stool samples and clinical follow-up data from a large number of heart failure patients with reduced cardiac pumping capacity were examined in detail. The metabolic data obtained showed a direct relationship between an increase in the amount of bacteria producing butyrate and short-chain fatty acids, a decline in systemic inflammation in the body, and the preservation of vascular health.
Cardiologists and microbiome experts are drawing attention to the vital importance of this biological mechanism, known as the "gut-heart axis." A healthy gut flora protects the intestinal barrier and prevents toxic substances from entering the bloodstream; otherwise, endotoxins leaking into the circulation trigger systemic inflammation, increasing the burden on and damage to the already weakened heart muscle.
Scientists state that the findings pave the way for new-generation supportive strategies focused on micronutrition and probiotics in the treatment of heart failure. It is anticipated that optimizing gut health through personalized diet protocols, prebiotic supplements, or treatments targeting specific bacterial strains will be a revolutionary step in increasing the life expectancy and quality of life of cardiovascular patients.
